Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis - PubMed (original) (raw)
. 2005 Jul 15;106(2):477-84.
doi: 10.1182/blood-2004-08-2989. Epub 2005 Apr 5.
Affiliations
- PMID: 15811962
- DOI: 10.1182/blood-2004-08-2989
Free article
Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis
Neil P Rodrigues et al. Blood. 2005.
Free article
Abstract
The zinc finger transcription factor GATA-2 plays a fundamental role in generating hematopoietic stem-cells in mammalian development. Less well defined is whether GATA-2 participates in adult stem-cell regulation, an issue we addressed using GATA-2 heterozygote mice that express reduced levels of GATA-2 in hematopoietic cells. While GATA-2+/- mice demonstrated decreases in some colony-forming progenitors, the most prominent changes were observed within the stem-cell compartment. Heterozygote bone marrow had a lower abundance of Lin(-)c-kit(+)Sca-1(+)CD34- cells and performed poorly in competitive transplantation and quantitative week-5 cobblestone area-forming cell (CAFC) assays. Furthermore, a stem-cell-enriched population from GATA1+/- marrow was more quiescent and exhibited a greater frequency of apoptotic cells associated with decreased expression of the anti-apoptotic gene Bcl-xL. Yet the self-renewal potential of the +/- stem-cell compartment, as judged by serial transplantations, was unchanged. These data indicate compromised primitive cell proliferation and survival in the setting of a lower GATA-2 gene dose without a change in the differentiation or self-renewal capacity of the stem-cells that remain. Thus, GATA-2 dose regulates adult stem-cell homeostasis by affecting select aspects of stem cell function.
Similar articles
- Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.
Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM, Nienhuis AW. Persons DA, et al. Blood. 1999 Jan 15;93(2):488-99. Blood. 1999. PMID: 9885210 - Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.
Li HS, Jin J, Liang X, Matatall KA, Ma Y, Zhang H, Ullrich SE, King KY, Sun SC, Watowich SS. Li HS, et al. Eur J Haematol. 2016 Sep;97(3):261-70. doi: 10.1111/ejh.12719. Epub 2016 Jan 14. Eur J Haematol. 2016. PMID: 26660446 Free PMC article. - GATA-related hematologic disorders.
Shimizu R, Yamamoto M. Shimizu R, et al. Exp Hematol. 2016 Aug;44(8):696-705. doi: 10.1016/j.exphem.2016.05.010. Epub 2016 May 25. Exp Hematol. 2016. PMID: 27235756 Review. - GATA switches as developmental drivers.
Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S. Bresnick EH, et al. J Biol Chem. 2010 Oct 8;285(41):31087-93. doi: 10.1074/jbc.R110.159079. Epub 2010 Jul 29. J Biol Chem. 2010. PMID: 20670937 Free PMC article. Review.
Cited by
- Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy.
Dancy E, Stratton P, Pichard DC, Marciano BE, Cowen EW, McBride AA, Van Doorslaer K, Merideth MA, Salmeri N, Hughes MS, Heller T, Parta M, Hickstein DD, Kong HH, Holland SM, Zerbe CS. Dancy E, et al. Front Immunol. 2024 Aug 29;15:1445711. doi: 10.3389/fimmu.2024.1445711. eCollection 2024. Front Immunol. 2024. PMID: 39267745 Free PMC article. - Malignant progression of preleukemic disorders.
Hall T, Gurbuxani S, Crispino JD. Hall T, et al. Blood. 2024 May 30;143(22):2245-2255. doi: 10.1182/blood.2023020817. Blood. 2024. PMID: 38498034 Review. - Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
Katsumura KR, Liu P, Kim JA, Mehta C, Bresnick EH. Katsumura KR, et al. Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317147121. doi: 10.1073/pnas.2317147121. Epub 2024 Feb 29. Proc Natl Acad Sci U S A. 2024. PMID: 38422019 Free PMC article. - Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins DJ, Pavletich TS, Patil AT, Pahopos D, Lasarev M, Polaki US, Gahvari ZJ, Bresnick EH, Matson DR. Robbins DJ, et al. Blood Adv. 2024 Jan 9;8(1):80-92. doi: 10.1182/bloodadvances.2023011554. Blood Adv. 2024. PMID: 38029365 Free PMC article. - TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.
Heyes E, Wilhelmson AS, Wenzel A, Manhart G, Eder T, Schuster MB, Rzepa E, Pundhir S, D'Altri T, Frank AK, Gentil C, Woessmann J, Schoof EM, Meggendorfer M, Schwaller J, Haferlach T, Grebien F, Porse BT. Heyes E, et al. Nat Commun. 2023 Oct 4;14(1):6185. doi: 10.1038/s41467-023-41927-x. Nat Commun. 2023. PMID: 37794021 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials